• Friday, Oct 02, 2020
  • Last Update : 12:21 am

AstraZeneca in first Covid-19 vaccine deal with Chinese company

  • Published at 05:15 pm August 6th, 2020
AstraZeneca in New York, US
File Photo: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, US, April 8, 2019 Reuters

The Shenzhen-based company must have capacity to produce at least 200 million doses by the end of next year as part of the exclusive framework agreement

Shenzhen Kangtai Biological Products will produce AstraZeneca Plc's potential Covid-19 vaccine in mainland China, the British drug maker said on Thursday, its first deal to supply one of the world's most populous countries.

The deal underscores Astra's frontrunner position in a global race to deliver an effective vaccine, given that Chinese ventures are leading at least eight of the 26 global vaccine development projects currently testing on humans.

Under the agreement Shenzhen Kangtai, one of China's top vaccine makers, will ensure it has annual production capacity of at least 100 million doses of the experimental shot AZD1222, which AstraZeneca co-developed with researchers at Oxford University, by the end of this year, AstraZeneca said.

The Shenzhen-based company must have capacity to produce at least 200 million doses by the end of next year as part of the exclusive framework agreement, its statement on the Chinese social media site WeChat said.

The two companies will also explore the possibility of cooperation on the vaccine candidate in other markets, AstraZeneca said.

They did not respond to requests for further comment.

There are no approved vaccines for Covid-19, the highly contagious respiratory illness caused by the coronavirus.

AstraZeneca has signed manufacturing deals globally including the United States, Britain, South Korea and Brazil, resulting in a target to make more than 2 billion doses of the vaccine.

For China, this marks another major deal to secure access to a Covid-19 vaccine developed by a foreign company as the country's other potential shots under development enter late stage of human trials.

Other collaborations between Chinese and Western players include a tie-up between Germany's BioNTech and Fosun, as well as one between Inovio Pharma and Beijing Advaccine Biotechnology.

The scramble for treatments and vaccines to curb the pandemic has boosted global pharmaceutical companies' shares, particularly those in China.

Shenzhen Kangtai's market value has surged almost 90% to about $20 billion over the past month, with shares hitting all-time highs on Tuesday. The Shenzhen-listed stock was down 10% on Thursday.

In 2019, the company, whose main products are vaccines for Hepatitis B, flu and measles and rubella, reported net profits of $37.4 million on revenue of 1.94 billion.

57
56
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail